Get a Sample

Free of cost and delivery

Ask
|
|
|
|
|
|
Home 9 Uncategorized 9 Acemannan & Skin Regeneration: Dermal Repair and Systemic Renewal ( Page 5 )

Acemannan & Skin Regeneration: Dermal Repair and Systemic Renewal

Relationship of Acemannan and Skin: From Dermal Regeneration to Systemic BMP2–Driven Tissue Renewal

Synopsis: Acemannan can be described as a skin-centric, systemically active Aloe polysaccharide that orchestrates proliferative, proangiogenic, and osteo/dentinogenic programs from the dermis outward to hard tissues, with BMP-2 as a key downstream effector.

Acemannan, an Aloe vera-derived acetylated glucomannan, promotes fibroblast and keratinocyte proliferation and migration, accelerating cutaneous wound closure and granulation tissue formation through activation of the AKT/mTOR axis (Xing et al., 2015). In gingival and dermal fibroblasts, acemannan upregulates keratinocyte growth factor-1 (KGF-1), vascular endothelial growth factor (VEGF), and type I collagen, supporting epithelial resurfacing, neovascularization, and matrix remodeling as core elements of skin repair (Jettanacheawchankit et al., 2009). Beyond the oral cavity, similar VEGF- and collagen-linked responses have been reported in bone marrow stromal cells and dermal models, reinforcing acemannan’s role as a bioactive matrix modulator rather than a passive hydrocolloid (Boonyagul et al., 2014; Bai et al., 2023). Mechanistically, acemannan-induced AKT/mTOR signaling integrates with broader growth factor networks and has been associated with enhanced expression of fibroblast growth factors and TGF-β1 in Aloe polysaccharide–treated skin, converging on fibroblast proliferation, myofibroblast differentiation, and collagen type I synthesis to drive dermal regeneration (Xing et al., 2015; Lee, 2024).

As a systemically responsive biomaterial, acemannan also promotes hard-tissue and dentin–pulp complex repair by stimulating proliferation, alkaline phosphatase activity, mineralization, and the expression of type I collagen, VEGF, and bone morphogenetic protein-2 (BMP-2) in bone marrow stromal cells and dental pulp cells, resulting in enhanced bone formation and dentin bridge regeneration in vivo (Boonyagul et al., 2014; Songsiripradubboon et al., 2017; Mehrabani et al., 2024). Upregulation of BMP-2 and related osteogenic markers positions acemannan as a BMP-2–linked, osteoinductive stimulus that can couple soft-tissue repair in the skin and oral mucosa to subsequent bone and dentin regeneration, aligning with its emerging classification as a longevity-oriented regenerative biomaterial (Boonyagul et al., 2014; Songsiripradubboon et al., 2017; Tabatabaeian et al., 2023). While evidence directly connecting acemannan to EGFR, PKC, and other specific receptor-level pathways in human skin remains more limited and is often extrapolated from broader Aloe polysaccharide or Aloe gel data, the available preclinical literature consistently supports a model in which acemannan functions as a skin-anchored, systemically active glycobiomaterial that coordinates growth factor signaling, collagenous matrix renewal, angiogenesis, and BMP-2–driven hard-tissue regeneration across multiple tissues (Xing et al., 2015; Jettanacheawchankit et al., 2009; Boonyagul et al., 2014; Songsiripradubboon et al., 2017; Bai et al., 2023).

Source of validity: Scientific

Keywords: Acemannan; Aloe vera; Biomaterial; Clinical study; Histopathological evaluation; Vital pulp therapy.

Key Mechanisms of Cellular Renewal of Acemannan.

Acemannan’s cellular renewal activity is supported by dental, bone, and soft-tissue models showing stimulation of BMP-2–driven osteogenic and odontogenic differentiation alongside fibroblast-mediated matrix renewal.

Although the most visible regenerative effects of acemannan are documented in dermal and oral mucosal tissues, its bioactivity clearly extends to mineralized structures such as bone and dentin. In bone marrow and dental pulp stem cell systems, acemannan upregulates bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF), alkaline phosphatase, dentin sialoprotein, and type I collagen, thereby driving osteogenic and odontogenic differentiation and matrix mineralization (Mehrabani et al., 2024; Songsiripradubboon et al., 2017; Jittapiromsak et al., 2010). This coordinated growth factor and matrix protein induction promotes the formation of new bone and reparative dentin, effectively renewing hard tissues in mandibular defects, extraction sockets, and pulpotomy sites.

Across dermal, oral, and skeletal models, acemannan functions as a bioactive scaffold that supports stem and progenitor cell proliferation while biasing their fate toward tissue-appropriate lineages via BMP-2–linked osteogenesis and dentinogenesis, VEGF-mediated angiogenesis, and enhanced type I collagen synthesis (Mehrabani et al., 2024; Songsiripradubboon et al., 2017). These findings indicate that its multi-tissue efficacy is rooted in fundamental mammalian pathways governing cell survival, proliferation, differentiation, and extracellular matrix remodeling, rather than in a single organ-specific effect. From an integrative biochemistry perspective, acemannan exemplifies how a plant-derived polysaccharide can act both as a structural matrix and as a molecular “instruction set,” supplying a hydrated, space-maintaining scaffold while triggering intracellular signaling programs that enable tissues to reenter a constructive, repair-oriented state (Mehrabani et al., 2024; Songsiripradubboon et al., 2017).

By bridging immune modulation, growth factor upregulation, and metabolic support of proliferating cells, acemannan emerges as a promising candidate for strategies aimed at promoting tissue regeneration and supporting healthy biological longevity, particularly in oral and orthopedic indications where BMP-2–centric pathways are central to successful repair (Jittapiromsak et al., 2010; Mehrabani et al., 2024).

Relationship of Acemannan and Skin: Systemic Implications for Cellular Renewal and Regeneration

Acemannan’s relationship with skin and hard tissues is best documented in fibroblast, keratinocyte, dental pulp, and bone-marrow stem-cell models, which together show a consistent profile of proliferation, migration, growth-factor upregulation, and matrix regeneration.

Acemannan significantly accelerates the proliferation and migration of multiple regenerative cell types, including skin primary fibroblasts, keratinocytes, dental pulp cells, and bone marrow–derived stem cells, all of which are essential for repairing damaged soft and hard tissues (Xing et al., 2015; Jettanacheawchankit et al., 2009; Songsiripradubboon et al., 2017; Mehrabani et al., 2024). In cutaneous models, acemannan speeds wound closure and increases proliferation markers such as Ki-67 and cyclin D1 in fibroblasts, indicating a robust push through the cell-cycle machinery during tissue repair (Xing et al., 2015). In oral and maxillofacial systems, it enhances proliferation and mineralizing activity of dental pulp stem cells and bone marrow stem cells, linking its skin-centric biology to deeper systemic and skeletal regeneration (Songsiripradubboon et al., 2017; Mehrabani et al., 2024). Altogether, these models support acemannan as a bioactive polysaccharide that coordinates cellular renewal across skin, mucosa, dentin, and bone (Jettanacheawchankit et al., 2009; Mehrabani et al., 2024).

Contenido del artículo

How Acemannan Activates Proliferation Pathways and Growth Factors

Acemannan promotes fibroblast proliferation partly by activating the AKT/mTOR signaling pathway, which enhances translation of cyclin D1 and drives the transition from G1 to S phase of the cell cycle (Xing et al., 2015). Pharmacologic inhibition of AKT or mTOR with rapamycin or AKT inhibitor VIII abolishes this cyclin D1 upregulation and the associated increase in fibroblast proliferation, confirming that the AKT/mTOR axis is a critical node for its proregenerative effects (Xing et al., 2015). In vivo, the same pathway activation correlates with faster reepithelialization and improved quality of the newly formed tissue in mouse skin wounds (Xing et al., 2015).

In keratinocytes, Aloe polysaccharide fractions enriched in acemannan activate epidermal growth factor receptor (EGFR), protein kinase C (PKC), and AKT/PKB, resulting in enhanced keratinocyte proliferation and migration—two key processes for rapid epidermal repair (Cheng et al., 2025). EGFR blockade with osimertinib suppresses acemannan-induced cell growth and migration, whereas PKC inhibition modulates these responses, indicating that constitutive EGFR signaling is a positive regulator of keratinocyte proliferation, while PKC exerts a more complex, context-dependent role (Cheng et al., 2025). Together, activation of AKT/mTOR in fibroblasts and EGFR/PKC/AKT in keratinocytes positions acemannan as an upstream regulator of coordinated dermal and epidermal proliferation during wound healing (Xing et al., 2015; Cheng et al., 2025).

Relationship of Acemannan with Growth Factor Stimulation and Collagen Synthesis

Acemannan stimulates the expression and secretion of several growth factors and extracellular matrix proteins that are central to tissue regeneration and remodeling across skin, oral tissues, and bone (Jettanacheawchankit et al., 2009; Songsiripradubboon et al., 2017; Mehrabani et al., 2024). In gingival fibroblasts, it increases keratinocyte growth factor-1 (KGF-1), vascular endothelial growth factor (VEGF), and type I collagen expression, tightly coupling fibroblast proliferation with enhanced matrix production and proangiogenic signaling (Jettanacheawchankit et al., 2009). In dental pulp and bone-related models, acemannan further elevates bone morphogenetic protein-2 (BMP-2), alkaline phosphatase (ALP) activity, and mineralization markers, extending its regenerative footprint from soft tissue into mineralized tissue (Songsiripradubboon et al., 2017; Mehrabani et al., 2024).

Relationship of Acemannan with Vascular Endothelial Growth Factor (VEGF): Acemannan upregulates VEGF in gingival fibroblasts and dental pulp cells, which supports angiogenesis and the formation of new capillaries in regenerating tissue (Jettanacheawchankit et al., 2009; Songsiripradubboon et al., 2017; Mehrabani et al., 2024). Increased VEGF expression contributes to better microcirculation and nutrient delivery in healing skin, mucosa, and bone defects, particularly relevant for compromised vascular beds.

Relationship of Acemannan with Keratinocyte Growth Factor-1 (KGF-1) and Fibroblast Growth Factors (FGF):In human gingival fibroblasts, acemannan significantly enhances KGF-1 expression, which acts in a paracrine fashion on keratinocytes to stimulate their proliferation and migration over the wound bed (Jettanacheawchankit et al., 2009). This KGF-1/FGF axis links fibroblast activation to efficient reepithelialization and can be leveraged conceptually for skin and oral care products targeting barrier repair and mucosal regeneration.

Relationship of Acemannan with Transforming Growth Factor-beta 1 (TGF-β1): Experimental wound-healing and bone-regeneration models describe acemannan as an inducer or modulator of TGF-β family signaling, which is central for wound contraction, fibroblast–myofibroblast transition, and collagen deposition (Mehrabani et al., 2024). Through this pathway, acemannan contributes to more organized granulation tissue and controlled matrix remodeling, supporting both faster closure and improved structural quality of the repaired tissue.

Relationship of Acemannan with Type I Collagen: Acemannan significantly increases type I collagen expression in gingival fibroblasts and dental pulp cells, often by 1.5- to 1.6-fold compared with untreated controls, and this is accompanied by enhanced mineralization in hard-tissue models (Jettanacheawchankit et al., 2009; Songsiripradubboon et al., 2017). Because type I collagen is the principal structural protein in dermis, periodontal ligament, and bone matrix, this collagen-stimulating effect supports applications ranging from skin antiaging and scar management to periodontal and endodontic repair.

Contenido del artículo

Relationship of Acemannan with Bone Morphogenetic Protein-2 (BMP-2): Acemannan elevates BMP-2 expression in dental pulp cells, bone marrow stem cells, and bone regeneration models, in some cases increasing BMP-2 levels more than fivefold compared with controls (Songsiripradubboon et al., 2017; Mehrabani et al., 2024). BMP-2 is crucial for osteoblast differentiation, dentinogenesis, and hard-tissue bridge formation, so its upregulation by acemannan explains the observed stimulation of dentin regeneration and alveolar bone healing in preclinical studies (Songsiripradubboon et al., 2017; Mehrabani et al., 2024).

Integrated View: From Skin to Systemic Tissue Renewal

By converging on AKT/mTOR, EGFR/PKC/AKT, VEGF, KGF-1, TGF-β, type I collagen, and BMP-2, acemannan orchestrates a multilayered response that links epidermal closure, dermal matrix rebuilding, angiogenesis, and bone/dentin regeneration within one polysaccharide-driven network (Xing et al., 2015; Jettanacheawchankit et al., 2009; Songsiripradubboon et al., 2017; Mehrabani et al., 2024; Cheng et al., 2025). This systems view supports positioning acemannan not just as a generic soothing Aloe component, but as a structured, signal-active biomaterial capable of coordinating soft-tissue repair at the skin surface with deeper skeletal and dentin renewal through BMP-2–centric pathways.

Contenido del artículo

AMB WELLNESS has developed a proprietary with a unique process isolating Acemannan from Aloe Vera Inner Gel with a high content of Acemannan ranging from 10% up to 25% measured by Nuclear Magnetic Resonance (NMR). Designed for high-end cosmetics, healthcare, and nutraceutical applications, Acetypol™ redefines efficacy, supporting skin hydration, barrier function, immune modulation, and gut health,positioning AMB WELLNESS at the forefront of innovation where scientific precision, purity, and performance meet unmatched effectiveness. Acetypol™ offers a more reliable and scientifically controlled alternative to conventional Aloe products, enabling formulators to achieve reproducible results by treating acetylation, purity, and molecular weight as key quality parameters rather than variable outcomes of processing.Acetypol™ offers a more reliable and scientifically controlled alternative to conventional Aloe products, enabling formulators to achieve reproducible results by treating acetylation, purity, and molecular weight as key quality parameters rather than variable outcomes of processing.Acetypol™ is a highly standardized Aloe vera–derived ingredient enriched to 15–20% acemannan with a high degree of acetylation (DA), controlled molecular weight, and high purity.

Contenido del artículo

Share it on:

Latest News

Share it on: